Drug Free Solution
(OTC) DSOL
Drug Free Solution Financials at a Glance
Market Cap
$56.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$2.10
Net Income (TTM)
-$10.59K
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-15.87 (Low)
Dividend
$0.00
Beta (Volatility)
-15.87 (Low)
Price
$0.00
Volume
4
Open
$0.00
Price
$0.00
Volume
4
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.10
Estimated Earnings Date
N/A
Dividend
$0.00
Beta (Volatility)
-15.87 (Low)
Price
$0.00
Volume
4
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.10
Estimated Earnings Date
N/A
DSOL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Drug Free Solution
Industry
Healthcare Providers and Services
Sector
Health CareCEO
Jessica Bass
Website
www.drugfreesolution.comHeadquarters
El Segundo, CA 90245, US
DSOL Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
2.58%
Return on Capital
N/A
Return on Assets
-12.74%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$56.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
283.40M
Volume
4
Avg. Volume
155.081
Financials (TTM)
Gross Profit
-$0.83
Operating Income
-$10.59K
EBITDA
-$250.04K
Operating Cash Flow
-$735.45
Capital Expenditure
-$27.66
Free Cash Flow
-$763.11
Cash & ST Invst.
$7.12
Total Debt
$0.00
Drug Free Solution Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$56.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$28.35K
N/A
Employees
2
N/A
Net Income
-$8.41K
-16548.8%
EBITDA
-$8.41K
+83.3%
Quarterly Fundamentals
Total Cash
$7.12
-72.8%
Total Debt
$0.00
-100.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-12.74%
N/A
Return on Invested Capital
2.38%
N/A
Free Cash Flow
-$102.51
-185.5%
Operating Cash Flow
-$102.51
-179.9%